Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 21 - What They Never Told You

How CEOs can lead in a recession and come out stronger: 5 powerful strategies from corner-office veterans

Battle-tested business leaders from CVS, Southwest Airlines, Honeywell and other Fortune 500 companies share their best ideas for navigating a downturn.

Fortune · Dec 1, 2022

Terrell Owens says man he punched at CVS threatened him, fan

Retired NFL star Terrell Owens said a fight caught on camera in which he punched a man in a CVS parking lot was the result of an “aggressor” threatening him and a fan he was talking to at the California store

The Independent UK · Nov 30, 2022

Delphi murders: What we know about suspect Richard Allen

Richard Allen is a married 50-year-old man who worked in the local CVS store in the heart of Delphi – where Libby German and Abby Williams lived with their families

The Independent UK · Nov 30, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Why the tourniquet, a relic from the earliest days of medicine, is back amid the gun violence epidemic

PHILADELPHIA —The way the blood spurted from the bullet wound, Lt. Robert Friel knew he didn't have long.

The Philadelphia Inquirer · Nov 28, 2022

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

StockNews.com · Nov 24, 2022

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Tribune News Service · Nov 23, 2022

Be prepared: Surge of winter sickness likely on its way, city’s top doc says

If you haven’t had your COVID-19 fall 2022 booster, now is the time, Chicago Public Health Commissioner Dr. Allison Arwady said.

Chicago Sun-Times · Nov 22, 2022

Read news from The Economist, FT, and more,
with one subscription

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com · Nov 21, 2022

2 Dividend Stocks That Can See Your Portfolio Through Tough Times and Beyond

The market has been under pressure amid high inflation, rising interest rates, and a slowing economy. Amid lingering macro headwinds, dividend investing could help investors ensure a steady income stream. Therefore, quality dividend stocks, CVS Health (CVS) and Spok Holdings (SPOK) could be ideal investments to navigate through tough times…

StockNews.com · Nov 17, 2022

Walmart offers $3bn to settle lawsuits over role in opioid crisis

Tentative agreement would bring settlement total from lawsuits against various companies to more than $50bn.

Al Jazeera · Nov 15, 2022

Walmart agrees to pay $3.1B in opioid settlements after CVS and Walgreens’ $5B proposals

NEW YORK — Walmart agreed to pay $3.1 billion to resolve lawsuits accusing the pharmacy of selling drugs that contributed to the opioid epidemic, but denied the allegations and didn’t admit liability.

Tribune News Service · Nov 15, 2022

Biden's Student Loan Forgiveness Plan Is Unconstitutional, Says Federal Judge

Plus: Users surge on decentralized social media platform Mastodon, the fall of city drugstores, and more...

Reason · Nov 11, 2022

1 Safe Stock You Can Buy and Hold Forever

Healthcare service provider CVS Health plans to venture into primary care after its Signify Health (SGFY) acquisition. Along with fundamental strength, the steady income stream offered by the company through dividends makes this stock a strong buy-and-hold-forever candidate. Read on….

StockNews.com · Nov 11, 2022

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

StockNews.com · Nov 9, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service · Nov 9, 2022

Defense Department health plan cuts its pharmacy network by nearly 15,000 outlets

Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay but also has the option of using a regular pharmacy through Tricare, the Defense…

Chicago Sun-Times · Nov 7, 2022

Walgreens’ VillageMD buys another urgent and primary care chain for $9 billion

Walgreens and rival CVS have evolved in recent years far beyond their historic focus on store sales and filling prescriptions.

The Texas Tribune · Nov 2, 2022

Texas could get $276 million from opioid settlement with CVS Pharmacy

Attorney General Ken Paxton’s office announced that the state is signing on to the $5 billion proposed settlement but hasn’t yet disclosed how its share of the money would be spent if the deal is finalized.

France 24 · Nov 2, 2022

US pharmacies announce opioid settlements totaling $10 billion

The two largest US pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle on Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart, a third pharmacy behemoth, is in discussions for a deal.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Nov 2, 2022

CVS Health Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Independent UK · Nov 2, 2022

Delphi murders suspect Richard Allen involved in ‘domestic incident’ two years before killings

Libby, 14, and Abby, 13, were murdered in 2017 after setting off on a hike along the Monon High Bridge Trail in their hometown of Delphi

Al Jazeera · Nov 2, 2022

US pharmacy companies reach $10bn settlement over opioid claims

The deals mean CVS and Walgreens will pay more than $10bn for their roles in the US opioid crisis.

Chicago Sun-Times · Nov 2, 2022

CVS, Walgreens announce opioid settlements totaling $10 billion

CVS and Walgreens have agreed in principle to pay a total of about $10 billion to settle lawsuits over the toll of powerful prescription opioids.

StockNews.com · Nov 2, 2022

1 Stock to Buy in Q4 if You Haven't Already

Health service provider CVS Health (CVS) is aiming for an $8 billion acquisition of Signify Health (SGFY). The company’s strength is reflected in its latest quarterly financials. Hence, the stock might be a solid buy in the fourth quarter. Let's find out….

WEKU · Nov 2, 2022

CVS and Walgreens announce opioid settlements totaling $10 billion

It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.

Benzinga · Nov 2, 2022

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

1 … 20 21 22 23

Coverage From

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.